Mirvetuximab soravtansine was the first ADC to show efficacy as a therapy for platinum-resistant ovarian cancer. Despite high ...
As the need to draw awareness to cervical, ovarian, uterine/endometrial, vaginal, and vulvar cancer becomes more evident, ...
Elahere was found to improve survival in patients with FR-alpha–positive, platinum-resistant, high-grade serous epithelial ...
This year health experts say 21,000 women will be diagnosed with Ovarian Cancer. It is often called a silent killer of women, ...
Medpage Today on MSN5d
Rucaparib-Nivolumab Maintenance Not the Answer in Newly Diagnosed Ovarian CancerAdding a PD-1 inhibitor to PARP inhibitor maintenance therapy failed to slow progression or improve survival in newly ...
New data show istisociclib (KB-0742) triggered cell death in preclinical ovarian cancer models of platinum and PARP-inhibitor ...
Kazia Therapeutics Limited (NASDAQ: KZIA), an oncology-focused drug development company, is pleased to announce the ...
AbbVie ABBV announced that the EMA’s Committee for Medicinal Products for Human Use (CHMP) recommended approving the ...
WOOD Grand Rapids on MSN21h
Event raises awareness for ovarian cancerSunday afternoon, the 12th annual Michigan Ovarian Cancer Alliance one mile walk/run was held. (Sept. 22, 2024) ...
GRAND RAPIDS, Mich. (WOOD) — A walk held in Grand Rapids Sunday aimed to bring awareness during National Ovarian Cancer Month. The 12th annual Michigan Ovarian Cancer Alliance one-mile walk/run was ...
From model Bianca Balti’s ovarian cancer diagnosis to hockey pro’s testicular cancer diagnosis, here’s what’s happening in ...
Dr. Diego Aviles with UT Physicians says symptoms of ovarian cancer typically include bloating, pain in the stomach or pelvis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback